An analysis of radiation necrosis of the central nervous system treated with bevacizumab

Journal of Neuro-Oncology

Volumn 117, Issue 2, 2014, Pages 321-327

  Tye, Karen ^a   Engelhard, Herbert H ^a   Slavin, Konstantin V ^a   Nicholas, M Kelly ^b   Chmura, Steven J ^b   Kwok, Young ^c   Ho, Dominic S ^a   Weichselbaum, Ralph R ^a,b   Koshy, Matthew ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

Bevacizumab; Brain tumors; Radiation; Radiation necrosis

Indexed keywords

BEVACIZUMAB; ANGIOGENESIS INHIBITOR; MONOCLONAL ANTIBODY;

ADULT; AGED; ANAPLASTIC GLIOMA; ARTICLE; ASPIRATION PNEUMONIA; BRAIN INJURY; BRAIN TUMOR; CANCER RADIOTHERAPY; CHILD; EXTERNAL BEAM RADIOTHERAPY; FEMALE; GLIOBLASTOMA; GLIOMA; HEMANGIOPERICYTOMA; HUMAN; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MENINGIOMA; METASTASIS POTENTIAL; MULTIPLE CYCLE TREATMENT; NASOPHARYNX CARCINOMA; PNEUMONIA; RADIATION DOSE; RADIATION NECROSIS; SAGITTAL SINUS THROMBOSIS; SEPSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; ADOLESCENT; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; MIDDLE AGED; NECROSIS; PATHOLOGY; RADIATION INJURIES; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL, HUMANIZED; BRAIN NEOPLASMS; CENTRAL NERVOUS SYSTEM; CHILD; FEMALE; HUMANS; MALE; MIDDLE AGED; NECROSIS; RADIATION INJURIES; YOUNG ADULT;

EID: 84901617716     PISSN: 0167594X     EISSN: 15737373     Source Type: Journal    
DOI: 10.1007/s11060-014-1391-8     Document Type: Article

References (33)

1. Levin VA, Bidaut L, Hou P, Kumar AJ, Wefel JS, Bekele BN, Grewal J, Prabhu S, Loghin M, Gilbert MR et al (2011) Randomized double-blind placebo-controlled trial of bevacizumab therapy for radiation necrosis of the central nervous system. Int J Radiat Oncol Biol Phys 79:1487-1495. doi: 10.1016/j.ijrobp.2009.12.061
2. Furuse M, Nonoguchi N, Kawabata S, Yoritsune E, Takahashi M, Inomata T, Kuroiwa T, Miyatake S (2013) Bevacizumab treatment for symptomatic radiation necrosis diagnosed by amino acid PET. Jpn J Clin Oncol 43:337-341. doi: 10.1093/jjco/hys231
3. Giglio P, Gilbert MR (2003) Cerebral radiation necrosis. Neurologist 9:180-188. doi: 10.1097/01.nrl.0000080951.78533.c4
4. Li YQ, Chen P, Jain V, Reilly RM, Wong CS (2004) Early radiation-induced endothelial cell loss and blood-spinal cord barrier breakdown in the rat spinal cord. Radiat Res 161:143-152
5. Nordal RA, Nagy A, Pintilie M, Wong CS (2004) Hypoxia and hypoxia-inducible factor-1 target genes in central nervous system radiation injury: a role for vascular endothelial growth factor. Clin Cancer Res 10:3342-3353. doi: 10.1158/1078-0432.CCR-03-0426
6. Nonoguchi N, Miyatake S, Fukumoto M, Furuse M, Hiramatsu R, Kawabata S, Kuroiwa T, Tsuji M, Fukumoto M, Ono K (2011) The distribution of vascular endothelial growth factor-producing cells in clinical radiation necrosis of the brain: pathological consideration of their potential roles. J Neurooncol 105:423-431. doi: 10.1007/s11060-011-0610-9
7. Baker DG, Krochak RJ (1989) The response of the microvascular system to radiation: a review. Cancer Investig 7:287-294
8. Remler MP, Marcussen WH, Tiller-Borsich J (1986) The late effects of radiation on the blood brain barrier. Int J Radiat Oncol Biol Phys 12:1965-1969
9. Rahmathulla G, Marko NF, Weil RJ (2013) Cerebral radiation necrosis: a review of the pathobiology, diagnosis and management considerations. J Clin Neurosci 20:485-502. doi: 10.1016/j.jocn.2012.09.011
10. Gonzalez J, Kumar AJ, Ca Conrad, Va Levin (2007) Effect of bevacizumab on radiation necrosis of the brain. Int J Radiat Oncol Biol Phys 67:323-326. doi: 10.1016/j.ijrobp.2006.10.010
11. Wong ET, Huberman M, Lu X, Mahadevan A (2008) Bevacizumab reverses cerebral radiation necrosis. J Clin Oncol 26:5649-5650. doi: 10.1200/JCO.2008.19.1866
12. Liu AK, Macy ME, Foreman NK (2009) Bevacizumab as therapy for radiation necrosis in four children with pontine gliomas. Int J Radiat Oncol Biol Phys 75:1148-1154. doi: 10.1016/j.ijrobp.2008.12.032
13. Torcuator R, Zuniga R, Mohan YS, Rock J, Doyle T, Anderson J, Gutierrez J, Ryu S, Jain R, Rosenblum M et al (2009) Initial experience with bevacizumab treatment for biopsy confirmed cerebral radiation necrosis. J Neurooncol 94:63-68. doi: 10.1007/s11060-009-9801-z
14. Jeyaretna DS, Curry WT, Batchelor TT, Stemmer-Rachamimov A, Plotkin SR (2011) Exacerbation of cerebral radiation necrosis by bevacizumab. J Clin Oncol 29:e159-e162. doi: 10.1200/JCO.2010.31.4815
15. Benoit A, Ducray F, Cartalat-Carel S, Psimaras D, Ricard D, Honnorat J (2011) Favorable outcome with bevacizumab after poor outcome with steroids in a patient with temporal lobe and brainstem radiation necrosis. J Neurol 258:328-329. doi: 10.1007/s00415-010-5747-5
16. Matuschek C, Bölke E, Nawatny J, Hoffmann TK, Peiper M, Orth K, Gerber PA, Rusnak E, Lammering G, Budach W (2011) Bevacizumab as a treatment option for radiation-induced cerebral necrosis. Strahlenther Onkol 187:135-139. doi: 10.1007/s00066-010-2184-4
17. Sanborn MR, Danish SF, Rosenfeld MR, O'Rourke D, Lee JYK (2011) Treatment of steroid refractory, Gamma Knife related radiation necrosis with bevacizumab: case report and review of the literature. Clin Neurol Neurosurg 113:798-802. doi: 10.1016/j.clineuro.2011.08.007
18. Arratibel-Echarren I, Albright K, Dalmau J, Rosenfeld MR (2011) Use of bevacizumab for neurological complications during initial treatment of malignant gliomas. Neurologia 26:74-80. doi: 10.1016/S2173-5808(11)70017-7
19. DeSalvo MN (2012) Radiation necrosis of the pons after radiotherapy for nasopharyngeal carcinoma: diagnosis and treatment. J Radiol Case Rep 6:9-16. doi: 10.3941/jrcr.v6i7.1108
20. Wang Y, Pan L, Sheng X, Mao Y, Yao Y, Wang E, Zhang N, Dai J (2012) Reversal of cerebral radiation necrosis with bevacizumab treatment in 17 Chinese patients. Eur J Med Res 17:25. doi: 10.1186/2047-783X-17-25
21. Gronier S, Bourg V, Frenay M, Cohen M, Mondot L, Thomas P, Lebrun C (2011) Bevacizumab for the treatment of cerebral radionecrosis. Rev Neurol 167:331-336. doi: 10.1016/j.neurol.2010.10.012
22. McPherson CM, Warnick RE (2004) Results of contemporary surgical management of radiation necrosis using frameless stereotaxis and intraoperative magnetic resonance imaging. J Neurooncol 68:41-47
23. Williamson R, Kondziolka D, Kanaan H, Lunsford LD, Flickinger JC (2008) Adverse radiation effects after radiosurgery may benefit from oral vitamin E and pentoxifylline therapy: a pilot study. Stereotact Funct Neurosurg 86:359-366. doi: 10.1159/000163557
24. Rizzoli HV, Pagnanelli DM (1984) Treatment of delayed radiation necrosis of the brain. A clinical observation. J Neurosurg 60:589-594. doi: 10.3171/jns.1984.60.3.0589
25. Leber KA, Eder HG, Kovac H, Anegg U, Pendl G (1998) Treatment of cerebral radionecrosis by hyperbaric oxygen therapy. Stereotact Funct Neurosurg 70(Suppl 1):229-236
26. Perez-Espejo MA, Garcia-Fernandez R, Tobarra-Gonzalez BM, Palma-Copete JD, Gonzalez-Lopez A, De la Fuente-Munoz I, Salinas-Ramos J, Felipe-Murcia M, Martinez-Lage JF, Fernandez-Perez J et al (2009) Usefulness of hyperbaric oxygen in the treatment of radionecrosis and symptomatic brain edema after LINAC radiosurgery. Neurocirugia 20:449-453
27. Kang KB, Wang TT, Woon CT, Cheah ES, Moore XL, Zhu C, Wong MC (2007) Enhancement of glioblastoma radioresponse by a selective COX-2 inhibitor celecoxib: inhibition of tumor angiogenesis with extensive tumor necrosis. Int J Radiat Oncol Biol Phys 67:888-896. doi: 10.1016/j.ijrobp.2006.09.055
28. Tsao MN, Li YQ, Lu G, Xu Y, Wong CS (1999) Upregulation of vascular endothelial growth factor is associated with radiation-induced blood-spinal cord barrier breakdown. J Neuropathol Exp Neurol 58:1051-1060
29. Gerstner ER, Duda DG, di Tomaso E, Ryg PA, Loeffler JS, Sorensen AG, Ivy P, Jain RK, Batchelor TT (2009) VEGF inhibitors in the treatment of cerebral edema in patients with brain cancer. Nat Rev Clin Oncol 6:229-236. doi: 10.1038/nrclinonc.2009.14
30. Cheung MC, Chan AS, Law SC, Chan JH, Tse VK (2003) Impact of radionecrosis on cognitive dysfunction in patients after radiotherapy for nasopharyngeal carcinoma. Cancer 97:2019-2026. doi: 10.1002/cncr.11295
31. Jain RK (2001) Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for combination therapy. Nat Med 7:987-989. doi: 10.1038/nm0901-987
32. Dai F, Shu L, Bian Y, Wang Z, Yang Z, Chu W, Gao S (2013) Safety of bevacizumab in treating metastatic colorectal cancer: a systematic review and meta-analysis of all randomized clinical trials. Clin Drug Investig 33:779-788. doi: 10.1007/s40261-013-0125-6
33. Merkenschlager A, Hirsch W, Syrbe S, Bernhard M, Wurm R (2011) Successful bevacizumab therapy for CNS radiation necrosis after stereotactic radiotherapy of an arteriovenous malformation. Neuropediatrics 42:P046